Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life in humans after IV administration.
Constraint: You must select all options from a, b, c, or d without using any other words.
Options:
a) CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
b) OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
c) NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
d) Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12
Answer: d
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
16-[3-(dimethylamino)propylamino]-13-methyl-11,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,8,12(17),13,15-octaen-5-ol